Clinical Trial Update: Lenalidomide in the Treatment of Mucosal Behçet's Syndrome [NA]

View source ↗

Summary

Clinical trial update indicates lenalidomide is being studied for mucosal Behçet's syndrome, with recruitment ongoing for oral ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Syndrome

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Oral Ulcer | NA | Status: RECRUITING